These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7034752)

  • 21. Rational approaches to the pharmacotherapy of chorea.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of frontal pole ablation on biogenic amine levels in the brain.
    Nielson HC
    Exp Neurol; 1966 Aug; 15(4):484-9. PubMed ID: 5911101
    [No Abstract]   [Full Text] [Related]  

  • 23. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 24. [Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
    Radouco-Thomas S
    Laval Med; 1970 Sep; 41(7):886-93. PubMed ID: 5515480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cerebral metabolic activator (author's transl)].
    Ishihara N; Gotoh F
    No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of GABA neurons in some neurological and psychiatric disorders (author's transl)].
    Pericić D
    Lijec Vjesn; 1979 Sep; 101(9):541-6. PubMed ID: 161601
    [No Abstract]   [Full Text] [Related]  

  • 27. L-dopa, parkinsonism, and involuntary movements.
    Mayer RF
    Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problems in the administration of L-DOPA (author's transl)].
    Ferrari E
    Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
    [No Abstract]   [Full Text] [Related]  

  • 30. [Extrapyramidal and presenile dementia. Relation between symptoms of dementia and cerebral transmitters, particularly dopamine].
    Kristensen V
    Ugeskr Laeger; 1976 Aug; 138(34):2047-50. PubMed ID: 184570
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine and dopamine metabolites in Parkinson's disease-a review.
    Barbeau A
    Proc Aust Assoc Neurol; 1968; 5(1):95-100. PubMed ID: 4885282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biochemistry and treatment of Parkinson's disease].
    Barbeau A
    Laval Med; 1970 Sep; 41(7):902-5. PubMed ID: 5509487
    [No Abstract]   [Full Text] [Related]  

  • 33. The probenecid test.
    Korczyn AD
    J Neural Transm Suppl; 1983; 19():173-83. PubMed ID: 6142088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology of choreatic movement disorders.
    Klawans HL; Weiner WJ
    Prog Neurobiol; 1976; 6(1):49-80. PubMed ID: 132681
    [No Abstract]   [Full Text] [Related]  

  • 35. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurology in 1977].
    Rosa A
    Rev Prat; 1977 Jun; 27(35):2215-20. PubMed ID: 143056
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some therapeutic effects of GABA in neurology (author's transl)].
    Borromei A
    Riv Patol Nerv Ment; 1974 Aug; 95(4):300-22. PubMed ID: 4157162
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.